Amundi Has $25.08 Million Holdings in Chemed Corporation $CHE

Key Points

• Amundi increased its Chemed stake by 51.5% in the second quarter to 53,856 shares, valued at approximately $25.08 million. Institutional investors collectively own 95.85% of the company.
• Chemed beat quarterly expectations with $6.06 EPS and $673.25 million in revenue, while revenue rose 8.8% year over year. The company also raised its quarterly dividend from $0.60 to $0.70 per share.
• Analyst sentiment remains cautious, with one Buy rating and five Holds producing a consensus “Hold” rating and a $530.75 price target. Meanwhile, company insiders sold approximately $2.8 million of shares during the last quarter.

Amundi increased its position in Chemed Corporation (NYSE:CHE - Free Report) by 51.5% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 53,856 shares of the company's stock after purchasing an additional 18,301 shares during the period. Amundi owned about 0.41% of Chemed worth $25,083,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Chemed in the 2nd quarter worth about $410,000. California State Teachers Retirement System increased its holdings in Chemed by 45,134.8% in the second quarter. California State Teachers Retirement System now owns 7,613,918 shares of the company's stock worth $3,546,106,000 after buying an additional 7,597,086 shares during the last quarter. HB Wealth Management LLC bought a new position in Chemed during the second quarter valued at approximately $542,000. Compass Financial Management LLC bought a new position in Chemed during the second quarter valued at approximately $52,000. Finally, Syon Capital LLC acquired a new stake in Chemed in the second quarter valued at approximately $235,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Chemed Stock Up 0.1%

NYSE CHE opened at $515.17 on Friday. The stock's 50 day moving average is $520.72 and its two-hundred day moving average is $453.39. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 1-year low of $365.20 and a 1-year high of $557.00. The company has a market capitalization of $6.73 billion, a price-to-earnings ratio of 25.87, a PEG ratio of 1.95 and a beta of 0.51.

Chemed (NYSE:CHE - Get Free Report) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The firm had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. During the same quarter in the previous year, the company posted $4.27 EPS. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities analysts forecast that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th were paid a $0.70 dividend. The ex-dividend date of this dividend was Monday, August 17th. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. This is a positive change from Chemed's previous quarterly dividend of $0.60. Chemed's dividend payout ratio (DPR) is 14.06%.

Insiders Place Their Bets

In other news, EVP Spencer S. Lee sold 1,000 shares of Chemed stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.04, for a total value of $541,040.00. Following the completion of the transaction, the executive vice president owned 13,912 shares of the company's stock, valued at $7,526,948.48. This trade represents a 6.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the sale, the chief executive officer directly owned 70,418 shares in the company, valued at approximately $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 5,190 shares of company stock valued at $2,803,460 in the last quarter. 3.33% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CHE. Oppenheimer boosted their price target on Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research report on Friday, July 31st. Royal Bank Of Canada boosted their price objective on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 30th. Weiss Ratings upgraded shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a research note on Friday, July 17th. Bank of America reaffirmed a "neutral" rating on shares of Chemed in a report on Wednesday, July 29th. Finally, Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. One analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $530.75.

About Chemed

Chemed Corporation is a diversified holding company that operates businesses in the healthcare and residential and commercial services industries. Its primary operations are conducted through VITAS Healthcare and Roto-Rooter.

VITAS Healthcare provides hospice and palliative care for patients with advanced illnesses. Its services are delivered in patients' homes, hospice residences, nursing facilities, hospitals and other care settings, primarily throughout the United States. Care is provided by interdisciplinary teams that may include physicians, nurses, hospice aides, social workers and chaplains.

Roto-Rooter provides plumbing and drain-cleaning services, as well as water cleanup and related services for residential and commercial customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.